Clinical trial
The Use of ACURATE Neo 2 Valve in Patients With Symptomatic Aortic Valve Stenosis
NCT05847751 is registered in ClinicalTrials.gov with Ceric Sàrl as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Use of ACURATE Neo 2 Valve in Patients With Symptomatic Aortic Valve Stenosis
- Lead sponsor
- Ceric Sàrl
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- March 6, 2024
- Completion date
- July 31, 2026
- Enrollment
- 51 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
severe aortic valve stenosis